PLG and hepatocellular carcinoma: In the study by Zanetto et al., 2021, HCC patients with cirrhosis had significantly lower plasmin–antiplasmin (PAP) complex levels than cirrhotic controls without HCC, reflecting reduced fibrinolytic activation despite similar individual factor levels [38].